Merck Awarded Australian CRISPR Nickase Patent for Foundationa...
DARMSTADT, Germany, Aug. 15, 2018 /PRNewswire-AsiaNet/ -- -- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research -- Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients...